Advancing Immuno-Oncology Therapies: What are the Next Generation Syngeneic Models?

Time: 9:40 am
day: Day One

Details:

• Which models/approaches to understand the mechanism of action?
• Immune-related adverse event (irAE) assessment of therapeutic antibodies with target specific KI models

Speakers: